[ET Net News Agency, 24 June 2021] ALPHAMAB-B (09966) rose 10% to HK$25.3.
It hits an intra-day high of HK$25.3, hitting a historical high, and an intra-day low of
HK$22.85. The total shares traded was 12.51 million, with a value of HK$304.75m. The
active buy/sell ratio is 63:37, with net buying turnover of HK$77.42m. MORGAN STANLEY HK
SEC accounts for greatest net responsive buying turnover of HK$14.12m, with volume
weighted average price of HK$24.354. CLSA LTD accounts for greatest net responsive selling
turnover of HK$22.71m, with volume weighted average price of HK$24.263. The stock has
risen a combined 22.22% over the past 6 consecutive trading days.
The Hang Seng Index now rose 66 points, or 0.23% to 28,883; the Hang Seng China
Enterprises Index now rose 10 points, or 0.1% to 10,684; the Hang Seng TECH Index now rose
22 points, or 0.28% to 8,042; with an overall turnover of HK$109.6b.
The SSE Composite Index now rose less than 1 point, with an overall turnover of
RMB461.27b.
The SZSE Component Index now fell 59 points, or 0.4% to 14,784, with an overall turnover
of RMB286.57b.

Basic Information
-------------------------------------------
Nominal 25.300 % Chg +10.00%
High 25.300 Low 22.850
Shares Tr 12.51m Turnover 304.75m
10-D SMA 22.095 %H.V 65.357
20-D SMA 20.940 VWAP 24.358
50-D SMA 17.566 RSI14 71.223
-------------------------------------------
Status: Hitting a historical high, active buy/sell ratio is 63:37, with net buying
turnover of HK$77.42m, rising a combined 22.22% over the past 6 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
ALPHAMAB-B (09966) 25.30 +10.00
GENSCRIPT BIO (01548) 34.90 +5.12
INNOVENT BIO (01801) 91.65 +1.78
JXR (01951) 21.00 -0.94
JW THERAP-B (02126) 31.90 Unchanged
CARSGEN-B (02171) 32.50 +2.20
WUXI BIO (02269) 138.30 -0.50
CSTONE PHARMA-B (02616) 17.92 +0.56
CANSINOBIO-B (06185) 423.60 +2.17
AKESO-B (09926) 64.15 +1.99
-------------------------------------------------
(ed)